JP2010502664A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502664A5
JP2010502664A5 JP2009527065A JP2009527065A JP2010502664A5 JP 2010502664 A5 JP2010502664 A5 JP 2010502664A5 JP 2009527065 A JP2009527065 A JP 2009527065A JP 2009527065 A JP2009527065 A JP 2009527065A JP 2010502664 A5 JP2010502664 A5 JP 2010502664A5
Authority
JP
Japan
Prior art keywords
chloro
hydroxy
cyclohexyl
phenylethynyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009527065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502664A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/007873 external-priority patent/WO2008031550A2/en
Publication of JP2010502664A publication Critical patent/JP2010502664A/ja
Publication of JP2010502664A5 publication Critical patent/JP2010502664A5/ja
Withdrawn legal-status Critical Current

Links

JP2009527065A 2006-09-11 2007-09-10 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体 Withdrawn JP2010502664A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06120424 2006-09-11
US86881406P 2006-12-06 2006-12-06
US86880506P 2006-12-06 2006-12-06
US88525507P 2007-01-17 2007-01-17
PCT/EP2007/007873 WO2008031550A2 (en) 2006-09-11 2007-09-10 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013260495A Division JP5860865B2 (ja) 2006-09-11 2013-12-17 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体

Publications (2)

Publication Number Publication Date
JP2010502664A JP2010502664A (ja) 2010-01-28
JP2010502664A5 true JP2010502664A5 (cg-RX-API-DMAC7.html) 2010-10-21

Family

ID=39184158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527065A Withdrawn JP2010502664A (ja) 2006-09-11 2007-09-10 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体
JP2013260495A Expired - Fee Related JP5860865B2 (ja) 2006-09-11 2013-12-17 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013260495A Expired - Fee Related JP5860865B2 (ja) 2006-09-11 2013-12-17 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体

Country Status (9)

Country Link
US (3) US20100041641A1 (cg-RX-API-DMAC7.html)
EP (2) EP2272509A1 (cg-RX-API-DMAC7.html)
JP (2) JP2010502664A (cg-RX-API-DMAC7.html)
KR (1) KR20090061041A (cg-RX-API-DMAC7.html)
AU (1) AU2007296964B2 (cg-RX-API-DMAC7.html)
CA (1) CA2663113A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009002684A (cg-RX-API-DMAC7.html)
RU (1) RU2014104384A (cg-RX-API-DMAC7.html)
WO (1) WO2008031550A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003913A (es) * 2007-10-12 2010-04-27 Novartis Ag Moduladores de los receptores de glutamato metabotropicos para el tratamiento de enfermedades de parkinson.
AU2012254934B2 (en) * 2007-10-12 2013-10-17 Novartis Ag Metabotropic glutamate receptor modulators for the treatment of Parkinson's disease
WO2010000763A2 (en) * 2008-06-30 2010-01-07 Novartis Ag Combination products
NZ590753A (en) * 2008-08-12 2012-06-29 Novartis Ag Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof
CA2774981A1 (en) * 2009-09-21 2011-03-24 Vanderbilt University O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators
US20130274294A1 (en) * 2010-12-20 2013-10-17 David Carcache 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
JP6715239B2 (ja) * 2014-09-11 2020-07-01 ヤンセン ファーマシューティカ エヌ.ベー. 置換2−アザ二環式化合物及びオレキシン受容体調節因子としてのその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521297A (en) 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
EP1165084A4 (en) 1999-03-03 2002-05-15 Merck & Co Inc INHIBITORS OF PRENYL PROTEIN TRANSFERASES
CH1196397H1 (de) * 1999-06-02 2007-05-31 Nps Pharma Inc Metabotrope Glutamatrezeptorantagonisten zur Behandlung von Krankheiten des zentralen Nervensystems.
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
SE0201943D0 (sv) 2002-06-20 2002-06-20 Astrazeneca Ab New use
WO2004014881A2 (en) 2002-08-09 2004-02-19 Astra Zeneca Ab '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
JP2006519251A (ja) * 2003-03-04 2006-08-24 アデックス ファーマシューティカルズ ソシエテ アノニム mGluR5アンタゴニストとしての新規アミノピリジン誘導体
US20060281803A1 (en) * 2003-09-23 2006-12-14 Lindsley Craig W Pyrazole modulators of metabotropic glutamate receptors
JP2007509935A (ja) 2003-10-31 2007-04-19 アストラゼネカ アクチボラグ アルキンズii
WO2005044266A1 (en) 2003-10-31 2005-05-19 Astrazeneca Ab Alkynes i
WO2005044265A1 (en) 2003-10-31 2005-05-19 Astrazeneca Ab Alkynes iii
EP1715867A4 (en) 2004-02-12 2009-04-15 Merck & Co Inc BIPYRIDYLAMIDE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5
DE102004020908A1 (de) * 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
TW200801005A (en) 2005-08-15 2008-01-01 Astrazeneca Ab Acetylenic piperazines as metabotropic glutamate receptor antagonists
BRPI0620066A2 (pt) * 2005-12-20 2011-11-01 Novartis Ag derivados de ácido nicotìnico como moduladores do receptor de glutamato metabotrópico, processo para preparação dos mesmos, composição farmacêutica e uso dos referidos derivados

Similar Documents

Publication Publication Date Title
JP2002053555A5 (cg-RX-API-DMAC7.html)
JP2007016035A5 (cg-RX-API-DMAC7.html)
CA2482551A1 (en) 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
WO2005020899A3 (en) Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
JP2004512328A5 (cg-RX-API-DMAC7.html)
ATE384058T1 (de) Thiazolderivate
DE60300021D1 (de) (S)-4-Amino-5-Chloro-2-Methoxy-N-[1-[1-(2-Tetrahydrofuryl-Carbonyl)-4-Piperidinylmethyl]-4-Piperidinyl]benzamid zur Behandlung von Magen-Darmbewegungskrankheiten
JP2010507096A5 (cg-RX-API-DMAC7.html)
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
JP2007506758A5 (ja) 4−(1−ベンゾフラン−3−イル−メチリデンアミノオキシ−プロポキシ)−安息香酸誘導体および線溶系の障害、血栓症の治療用のpai−1阻害剤としての関連化合物
ATE454372T1 (de) Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
NO20076424L (no) N-koblete heterocykliske antagonister av P2Y1 reseptoren nyttige for behandling av tromboseforstyrrelser
WO2001098268A3 (en) Piperidine amides as modulators of chemokine receptor activity
JP2018537507A5 (cg-RX-API-DMAC7.html)
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
WO2004098516A3 (en) Cyclic derivatives as modulators of chemokine receptor activity
NO20054070D0 (no) 4-[(2,4-diklor-5-metoksyfenyl)amino]-6-alkoksy-3-kinol inkarbonitriler for behandling av isjemisk skade.
RU2000100362A (ru) Применение специфического антагониста 5нт2 рецепторов для приготовления лекарств, пригодных для лечения синдрома апноэ во сне
DE60311942D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60303101D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
WO2007076140A3 (en) Treatment methods employing histamine h3 receptor antagonists, including betahistine
NO20070878L (no) Dimere piperidinderivater
WO2006115918A3 (en) Vla-4 antagonists